Hiroto Hatabu

1995–2025 年に発表

167
論文数
19,750
被引用数
85
h 指数
160
i10 指数

被引用数

Hiroto Hatabu の年別被引用数1990 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 4 件1998 年: 被引用 16 件1999 年: 被引用 50 件2000 年: 被引用 25 件2001 年: 被引用 35 件2002 年: 被引用 31 件2003 年: 被引用 28 件2004 年: 被引用 40 件2005 年: 被引用 17 件2006 年: 被引用 44 件2007 年: 被引用 47 件2008 年: 被引用 42 件2009 年: 被引用 39 件2010 年: 被引用 60 件2011 年: 被引用 54 件2012 年: 被引用 86 件2013 年: 被引用 94 件2014 年: 被引用 88 件2015 年: 被引用 99 件2016 年: 被引用 134 件2017 年: 被引用 162 件2018 年: 被引用 190 件2019 年: 被引用 563 件2020 年: 被引用 767 件2021 年: 被引用 805 件2022 年: 被引用 744 件2023 年: 被引用 557 件2024 年: 被引用 758 件2025 年: 被引用 337 件2026 年: 被引用 15 件1991〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,615 件、この内訳の 24.7%中国: 引用元論文 770 件、この内訳の 11.8%イギリス: 引用元論文 441 件、この内訳の 6.7%日本: 引用元論文 376 件、この内訳の 5.7%ドイツ: 引用元論文 350 件、この内訳の 5.4%イタリア: 引用元論文 308 件、この内訳の 4.7%フランス: 引用元論文 281 件、この内訳の 4.3%カナダ: 引用元論文 242 件、この内訳の 3.7%韓国: 引用元論文 207 件、この内訳の 3.2%オランダ: 引用元論文 180 件、この内訳の 2.8%スペイン: 引用元論文 178 件、この内訳の 2.7%オーストラリア: 引用元論文 132 件、この内訳の 2%
0%24.7%その他 22.3%

分野

  • Medicine81.5%
  • Biochemistry, Genetics and Molecular Biology5.4%
  • Physics and Astronomy5.3%
  • Immunology and Microbiology2.5%
  • Engineering2%
  • Computer Science1.6%
  • その他1.7%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis8.3%
  • Cancer Immunotherapy and Biomarkers7.7%
  • Lung Cancer Diagnosis and Treatment4.4%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.3%
  • Radiomics and Machine Learning in Medical Imaging3.2%
  • Lung Cancer Treatments and Mutations3.2%
  • その他69.9%

共著者

全論文

検索で開く
  1. Monitoring immune-checkpoint blockade: response evaluation and biomarker development

    著者: , , , - Nature Reviews Clinical Oncology 2017 被引用: 1,086

  2. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 被引用: 570

  3. Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

    著者: , , , , - JAMA Oncology 2016 被引用: 755

  4. Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 615

  5. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ayodeji Adegunsoye, Mary E. Strek, Margaret Neighbors, Xuting R. Sheng, Gunnar Guðmundsson, Vilmundur Guðnason, Hiroto Hatabu, David J. Lederer, Ani Manichaikul, John D. Newell, George O'connor, Victor E. Ortega, Hanfei Xu, Tasha E. Fingerlin, Yohan Bossé, Ke Hao, Philippe Joubert, David C. Nickle, Don D. Sin, Wim Timens, Dominic Furniss, Andrew P. Morris, Krina T. Zondervan, Ian P. Hall, Ian Sayers, Martin D. Tobin, Toby M. Maher, Michael H. Cho, Gary M. Hunninghake, David A. Schwartz, Brian L. Yaspan, Philip L. Molyneaux, Carlos Flores, Imre Noth, Gísli Jenkins, Louise V. Wain - American Journal of Respiratory and Critical Care Medicine 2019 被引用: 341

  6. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort Study

    著者: , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 被引用: 228

  7. Association Between Interstitial Lung Abnormalities and All-Cause Mortality

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher J. O’Donnell, Lenore J. Launer, Tamara B. Harrris, Vilmundur Guðnason, Edwin K. Silverman, George O'connor, George R. Washko, Iván O. Rosas, Gary M. Hunninghake, for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) and COPDGene Investigators - JAMA 2016 被引用: 465

  8. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality

    著者: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 被引用: 258

  9. Detection of Rheumatoid Arthritis–Interstitial Lung Disease Is Enhanced by Serum Biomarkers

    著者: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 被引用: 216

  10. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease

    著者: , , , , , , , , , , , , , , , - The Journal of Rheumatology 2020 被引用: 109

  11. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study

    著者: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 352

  12. Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society

    著者: , , , , , , , , , , , , , , , , , , , , , - Radiology 2021 被引用: 116

  13. PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course

    著者: , , , , , , , , , - Clinical Cancer Research 2016 被引用: 494

  14. Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis

    著者: , , , , , , - Radiology 2020 被引用: 168

  15. Interstitial Lung Abnormalities: State of the Art

    著者: , , , - Radiology 2021 被引用: 152

  16. Commonly Missed Findings on Chest Radiographs

    著者: , , - CHEST Journal 2022 被引用: 71

  17. MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 448

  18. Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper

    著者: , , , , , , , , , , , , , , - Radiology 2020 被引用: 184

  19. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , - CHEST Journal 2021 被引用: 128

  20. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 104

  21. The Proteomic Profile of Interstitial Lung Abnormalities

    著者: , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 49

  22. Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy

    著者: , , , , - New England Journal of Medicine 2015 被引用: 374

  23. Identification of Early Interstitial Lung Disease in Smokers from the COPDGene Study

    著者: , , , , , , , , , , , - Academic Radiology 2009 被引用: 233

  24. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management

    著者: , , , , , , , , , - European Journal of Radiology Open 2022 被引用: 81